Why Regeneron Pharmaceuticals Stock Topped the Market on Tuesday
The quarter saw Regeneron grow its revenue by 10% year over year to just under $3.79 billion. Although non-GAAP (adjusted) ...
Morgan Stanley cuts Regeneron stock price target to $1,150
Pharmaceuticals stock, reducing the price target from $1,185.00 to $1,150.00. Despite the decrease, the firm maintained its Overweight rating on the NASDAQ-listed company. According to InvestingPro ...
Amgen Surpasses Q4 Earnings Forecasts
Amgen reported strong fourth-quarter earnings, driven by strategic acquisitions and robust product sales growth.
HRMY vs. RGEN: Which Stock Is the Better Value Option?
Based on these metrics and many more, HRMY holds a Value grade of A, while RGEN has a Value grade of D. HRMY sticks out from RGEN in both our Zacks Rank and Style Scores models, so value investors ...
Barron's6d
Repligen Corp.
Stocks: Real-time U.S. stock quotes reflect trades reported through ... Sources: FactSet, Tullett Prebon Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange ...
Repligen (RGEN) Surges 3.7%: Is This an Indication of Further Gains?
Repligen (RGEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...